KELLI ROSSON: Open Payments
NPI 1497457634 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$732 in 23 payments from 10 companies in 2025. Trend: 2023 $724 · 2024 $986 · 2025 $732
Food & beverage: $732
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $363 |
| ABBVIE INC. | 5 | $135 |
| Indivior Inc. | 3 | $55 |
| GlaxoSmithKline, LLC. | 3 | $46 |
| Novo Nordisk Inc | 2 | $33 |
| Edwards Lifesciences Corporation | 1 | $28 |
| Lilly USA, LLC | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Exact Sciences Corporation | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: VRAYLAR, BREZTRI, FARXIGA, AIRSUPRA, SUBLOCADE, SHINGRIX, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), ZEPBOUND.
Industry payments across SC — which companies pay providers there.
